Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Spiros Miyakis, Michael D. Lockshin, Tatsuya Atsumi et al. · Journal of Thrombosis and Haemostasis · 2006 · 7K citations · Full text

Lipid Disorder, International Consensus Statement, Cardiovascular Disease +9

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

John T. Brandt, Douglas A. Triplett, Barbara M. Alving et al. · PubMed · 1995 · 1.2K citations

Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Treatment +11

Criteria for the Diagnosis of Lupus Anticoagulants: An Update

John T. Brandt, Douglas A. Triplett, Barbara M. Alving et al. · Thrombosis and Haemostasis · 1995 · 997 citations

Rheumatology, Thrombosis, Systemic Lupus Erythematosus +10

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

Bas de Laat, Ronald H. W. M. Derksen, Rolf T. Urbanus et al. · Blood · 2004 · 378 citations

Antibody profiles for the diagnosis of antiphospholipid syndrome

Alessandra Biasiolo, Cinzia Pegoraro, Umberto Cucchini et al. · Thrombosis and Haemostasis · 2005 · 315 citations